Foreign Filer Report • Nov 9, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update false
| ������' �� ��������� ���� | 2 380 |
| .LINEAGE CELL THERAPEUTICS, INC | |
| Corporation no: 876343 | 10834 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 09/11/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-084786 | Time of broadcast: 06:38 06:38 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onLineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Third_Quarter_2025_Financial_Results_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 06/08/2024 |
| Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389 | |
| E-mail address: [email protected] Company site: biotimeinc.com | |
| Previous names of reporting entity: .BIOTIME, INC | |
| Name of the Signatory: Gerzi SHNEOR Ilan Position of Signatory in the reporting corporation: Legal Adviser Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ | |
| Address: Derech Menachem Begin 121 , Tel Aviv 6701203 Telephone: 03-3039000 Facsimile: E-mail: [email protected] 1 | |
| U.S.A |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.